Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Application, By Technology, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global radiation oncology market size was exhibited at USD 7.91 billion in 2022 and is projected to hit around USD 15.72 billion by 2032, growing at a CAGR of 7.1% during the forecast period 2023 to 2032.

radiation oncology market size

Key Pointers:

  • The External Beam Radiation Therapy (EBRT) segment dominated the market for radiation oncology and accounted for the largest revenue share of 82.3% in 2022
  • The IMRT technology segment dominated the market for radiation oncology and accounted for the largest revenue share of 29.0% in 2022. 
  • The EBRT segment dominated the radiation oncology market and accounted for the largest revenue share of 82.0% in 2022.
  • In 2022, North America dominated the market for radiation oncology and accounted for the largest revenue share of more than 49.0%.
  • In Asia Pacific, the market for radiation oncology is projected to witness the highest growth rate over the forecast period.

Radiation oncology Market Report Scope

Report Coverage

Details

Market Size in 2023

USD 8.48 Billion

Market Size by 2032

USD 15.72 Billion

Growth Rate from 2023 to 2032

CAGR of 7.1%

Base Year

2022

Forecast Period

2023 to 2032

Segments Covered

Type, technology, application, region

 

The increasing prevalence of cancer, rising adoption of radiotherapy in cancer treatment, and technological advancements in radiotherapy equipment are some of the major factors driving the market. Technological advancements to improve treatment safety and efficacy are expected to drive the market for radiation oncology. 4D radiotherapy is a combination of 4D imaging and radiotherapy, which allows real-time tracking of a tumor and provides precise information regarding the tumor size, shape, area, and volume. This combination enables physicians to compensate for organ, tumor, or patient movement and deliver a conformal dose.

The key players are also entering strategic collaborations for the advancement of radiotherapy. For instance, in December 2019, Elekta AB collaborated with ViewRay, Inc. for the advancement of MR-guided therapy in oncology. This collaboration aimed to improve MR-Linac technology to benefit clinicians and patients with wider treatment options.

However, the lack of skilled radiotherapy professionals is one of the major factors restraining the growth of the market for radiation oncology. For instance, in developed countries, there are around 2-3 radiation oncologists per 1,000 cancer patients, whereas, Bangladesh report only 0.76 radiation oncologists per 1,000 cancer patients. Similar is the situation in India. Besides, there is a lack of training and education in radiation oncology among physicians in many countries.

The market for radiation oncology has also been negatively impacted due to the COVID-19 pandemic. Hospitals have delayed the purchase of capital equipment and redirected the resources towards the treatment of COVID-19. Additionally, there have also been delays in the installation of the already sanctioned equipment due to the pandemic.

Some of the prominent players in the Radiation oncology Market include:

  • Varian Medical Systems, Inc.
  • Elekta AB
  • Accuray Incorporated
  • Ion Beam Applications (IBA)
  • C.R. BARD, INC. (BD)
  • Isoray Medical
  • Mevion Medical Systems, Inc.
  • Nordion Inc.
  • NTP Radioisotopes SOC Ltd.
  • Curium Pharma
  • Viewray Technologies, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global radiation oncology market.

By Type 

  • External Beam Radiation Therapy
  • Linear Accelerators (Linac)
  • Compact Advanced Radiotherapy Systems
  • Cyberknife
  • Gamma Knife
  • Tomotherapy
  • Proton Therapy
  • Cyclotron
  • Synchrotron
  • Internal Beam Radiation Therapy
  • Brachytherapy
  • Seeds
  • Applicators and Afterloaders
  • Electronic Brachytherapy
  • Systemic Beam Radiation Therapy
  • Others

By Technology 

  • External Beam Radiation Therapy
  • Image-Guided Radiotherapy (IGRT)
  • Intensity Modulated Radiotherapy (IMRT)
  • Stereotactic Technology
  • Proton Beam Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
  • Brachytherapy
  • Low-Dose Rate Brachytherapy
  • High-Dose Rate Brachytherapy

By Application 

  • External Beam Radiation Therapy
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Head and Neck Cancer
  • Colorectal Cancer
  • Others
  • Internal Beam Radiation Therapy
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Cervical Cancer
  • Penile Cancer
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Chapter 1. Introduction

                 1.1 Market Segmentation and Scope

                      1.1.1 Segment Scope

                      1.1.2 Regional Scope

                      1.1.3 Estimates And Forecast Timeline:

                 1.2 Research Methodology

                 1.3 Information Procurement

                      1.3.1 Purchased Database:

                      1.3.2 nova one advisor’s Internal Database

                      1.3.3 Secondary Sources

                      1.3.4 Primary Research

                      1.3.5 Details Of Primary Research

                 1.4 Information Or Data Analysis

                      1.4.1 Data Analysis Models

                 1.5 Market Formulation & Validation

                 1.6 Model Details

                      1.6.1 Commodity Flow Analysis

                           1.6.1.1 Approach: Commodity Flow Approach

                 1.7 List of Secondary Sources

                 1.8 List of Abbreviations

                 1.9 Objectives

                      1.9.1 Objective 1

                      1.9.2 Objective 2

                      1.9.3 Objective 3

                      1.9.4 Objective 4

Chapter 2 Executive Summary

                 2.1 Market Summary

Chapter 3 Market Variables, Trends & Scope

                 3.1 Market Segmentation

                 3.2 Market Definitions

                 3.3 Market Driver Analysis

                      3.3.1 Rising Adoption Of Radiotherapy

                      3.3.2 Technological Advancements In Radiotherapy

                      3.3.3 Rising Prevalence Of Cancer

                      3.3.4 Increase In Healthcare Expenditure

                      3.3.5 Increasing Application Of Radiopharmaceuticals

                 3.4 Market Restraint Analysis

                      3.4.1 Lack Of Skilled Radiotherapy Professionals

                      3.4.2 Inadequate Radiation Infrastructure

                      3.4.3 Adverse Effects Of Radiotherapy

                 3.5 Key Opportunities Prioritized

                 3.6 Business Environment Analysis

                      3.6.1 Swot Analysis; By Factor (Political & Legal, Economic And Technological)

                      3.6.2 Porter’s Five Forces Analysis

                 3.7 Regulatory Landscape

                      3.7.1 North America

                      3.7.2 Europe

                      3.7.3 Asia Pacific

                      3.7.4 Latin America

                      3.7.5 Middle East And Africa

Chapter 4 Radiation Oncology Market - Segment Analysis, By Type, 2023 - 2032 

                 4.1 Radiation Oncology Market: Type Movement Analysis

                 4.2 External Beam Radiation Therapy

                      4.2.1 External Beam Radiation Therapy Market, 2023 - 2032 

                      4.2.2 Linear Accelerators

                           4.2.2.1 Linear Accelerators Market, 2023 - 2032 

                      4.2.3 Compact Advanced Radiotherapy Systems

                           4.2.3.1 Compact Advanced Radiotherapy Systems Market, 2023 - 2032 

                           4.2.3.2 Cyberknife

                                4.2.3.2.1 Cyberknife Market, 2023 - 2032 

                           4.2.3.3 Gamma Knife

                                4.2.3.3.1 Gamma Knife Market, 2023 - 2032 

                           4.2.3.4 Tomotherapy

                                4.2.3.4.1 Tomotherapy Compact Market, 2023 - 2032 

                      4.2.4 Proton Therapy

                           4.2.4.1 Proton Therapy Market, 2023 - 2032 

                           4.2.4.2 Cyclotron

                                4.2.4.2.1 Cyclotron Market, 2023 - 2032 

                           4.2.4.3 Synchrotron

                                4.2.4.3.1 Synchrotron Market, 2023 - 2032 

                 4.3 Internal Beam Radiation Therapy

                      4.3.1 Internal Beam Radiation Therapy Market, 2023 - 2032 

                      4.3.2 Brachytherapy

                           4.3.2.1 Brachytherapy Market, 2023 - 2032 

                           4.3.2.2 Seeds

                                4.3.2.2.1 Seeds Market, 2023 - 2032 

                           4.3.2.3 Applicators And Afterloaders

                                4.3.2.3.1 Applicators And Afterloaders Market, 2023 - 2032 

                           4.3.2.4 Electronic Brachytherapy

                                4.3.2.4.1 Electronic Brachytherapy Market, 2023 - 2032 

                      4.3.3 Systemic Beam Radiation Therapy

                           4.3.3.1 Systemic Beam Radiation Therapy Market, 2023 - 2032 

                      4.3.4 Others

                           4.3.4.1 Others Market, 2023 - 2032 

Chapter 5 Radiation Oncology Market - Segment Analysis, By Technology, 2023 - 2032 

                 5.1 Radiation Oncology Market: Technology Movement Analysis

                 5.2 External Beam Radiation Therapy (EBRT)

                      5.2.1 EBRT Market, 2023 - 2032 

                      5.2.2 Image-GUIDED Radiation Therapy (IGRT)

                           5.2.2.1 IGRT market, 2023 - 2032 

                      5.2.3 Intensity Modulated Radiotherapy (IMRT)

                           5.2.3.1 IMRT market, 2023 - 2032 

                      5.2.4 Stereotactic Technology

                           5.2.4.1 Stereotactic technology market, 2023 - 2032 

                      5.2.5 Proton Beam Therapy

                           5.2.5.1 Proton beam therapy market, 2023 - 2032 

                      5.2.6 3D Conformal Radiotherapy (3D-CRT)

                           5.2.6.1 3D-CRT market, 2023 - 2032 

                      5.2.7 Volumetric Modulated ARC Therapy (VMAT)

                           5.2.7.1 VMAT market, 2023 - 2032 

                 5.3 Brachytherapy

                      5.3.1 Brachytherapy MARKET, 2023 - 2032 

                      5.3.2 Low Dose Rate (LDR) Brachytherapy

                           5.3.2.1 LDR brachytherapy market, 2023 - 2032 

                      5.3.3 High Dose Rate (HDR) Brachytherapy

                           5.3.3.1 HDR brachytherapy market, 2023 - 2032 

Chapter 6 Radiation Oncology Market - Segment Analysis, By Application, 2023 - 2032 

                 6.1 Radiation Oncology Market: Application Movement Analysis

                 6.2 External Beam Radiation Therapy (EBRT)

                      6.2.1 Prostate cancer

                           6.2.1.1 Prostate cancer market, 2023 - 2032 

                      6.2.2 Breast cancer

                           6.2.2.1 Breast cancer market, 2023 - 2032 

                      6.2.3 Lung cancer

                           6.2.3.1 Lung cancer market, 2023 - 2032 

                      6.2.4 Head and neck cancer

                           6.2.4.1 Head and neck cancer market, 2023 - 2032 

                      6.2.5 Colorectal cancer

                           6.2.5.1 Colorectal cancer market, 2023 - 2032 

                      6.2.6 OTHERS

                           6.2.6.1 Others market, 2023 - 2032 

                 6.3 Internal Beam Radiation Therapy

                      6.3.1 Prostate Cancer

                           6.3.1.1 Prostate cancer market, 2023 - 2032 

                      6.3.2 Gynecological Cancer

                           6.3.2.1 Gynecological cancer market, 2023 - 2032 

                      6.3.3 Breast Cancer

                           6.3.3.1 Breast cancer market, 2023 - 2032 

                      6.3.4 Cervical Cancer

                           6.3.4.1 Cervical cancer market, 2023 - 2032 

                      6.3.5 Penile Cancer

                           6.3.5.1 Penile cancer market, 2023 - 2032 

                      6.3.6 Others

                           6.3.6.1 Others market, 2023 - 2032 

Chapter 7 Regional Business Analysis

                 7.1 Radiation Oncology Market: Regional Movement Analysis

                 7.2 North America

                      7.2.1 North America Market Estimates And Forecast, 2023 - 2032

                      7.2.2 U.S.

                           7.2.2.1 U.S. Market Estimates And Forecast, 2023 - 2032

                      7.2.3 Canada

                           7.2.3.1 Canada Market Estimates And Forecast, 2023 - 2032

                 7.3 Europe

                      7.3.1 Europe Market Estimates And Forecast, 2023 - 2032

                      7.3.2 Germany

                           7.3.2.1 Germany Market Estimates And Forecast, 2023 - 2032

                      7.3.3 U.K.

                           7.3.3.1 U.K. Market Estimates And Forecast, 2023 - 2032

                      7.3.4 France

                           7.3.4.1 France Market Estimates And Forecast, 2023 - 2032

                      7.3.5 Italy

                           7.3.5.1 Italy Market Estimates And Forecast, 2023 - 2032

                      7.3.6 Spain

                           7.3.6.1 Spain Market Estimates And Forecast, 2023 - 2032

                      7.3.7 Russia

                           7.3.7.1 Russia Market Estimates And Forecast, 2023 - 2032

                 7.4 Asia Pacific

                      7.4.1 Asia Pacific Market Estimates And Forecast, 2023 - 2032

                      7.4.2 Japan

                           7.4.2.1 Japan Market Estimates And Forecast, 2023 - 2032

                      7.4.3 China

                           7.4.3.1 China Market Estimates And Forecast, 2023 - 2032

                      7.4.4 India

                           7.4.4.1 India Market Estimates And Forecast, 2023 - 2032

                      7.4.5 South Korea

                           7.4.5.1 South Korea Market Estimates And Forecast, 2023 - 2032

                      7.4.6 Australia

                           7.4.6.1 Australia Market Estimates And Forecast, 2023 - 2032

                      7.4.7 Singapore

                           7.4.7.1 Singapore Market Estimates And Forecast, 2023 - 2032

                 7.5 Latin America

                      7.5.1 Latin America Market Estimates And Forecast, 2023 - 2032

                      7.5.2 Brazil

                           7.5.2.1 Brazil Market Estimates And Forecast, 2023 - 2032

                      7.5.3 Mexico

                           7.5.3.1 Mexico Market Estimates And Forecast, 2023 - 2032

                      7.5.4 Argentina

                           7.5.4.1 Argentina Market Estimates And Forecast, 2023 - 2032

                 7.6 Middle East & Africa

                      7.6.1 Middle East And Africa Market Estimates And Forecast, 2023 - 2032

                      7.6.2 South Africa

                           7.6.2.1 South Africa Market Estimates And Forecast, 2023 - 2032

                      7.6.3 Saudi Arabia

                           7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2023 - 2032

                      7.6.4 Uae

                           7.6.4.1 Uae Market Estimates And Forecast, 2023 - 2032

Chapter 8 Competitive Analysis

                 8.1 Vendor Landscape

                      8.1.1 List Of Key Distributors And Channel Partners

                      8.1.2 Key Company Market Share Analysis, 2020

                 8.2 Public Companies

                      8.2.1 Company Market Position Analysis

                      8.2.2 Competitive Dashboard Analysis

                 8.3 Private Companies

                      8.3.1 List Of Key Emerging Companies /Technology Disruptors/Innovators

                      8.3.2 Regional Network Map

                      8.3.3 Strategic Framework

                 8.4 Company Profiles

                      8.4.1 Varian Medical Systems, Inc.

                           8.4.1.1 Company overview

                           8.4.1.2 Financial performance

                           8.4.1.3 Product benchmarking

                           8.4.1.4 Strategic initiatives

                      8.4.2 Elekta AB

                           8.4.2.1 Company overview

                           8.4.2.2 Financial performance

                           8.4.2.3 Product benchmarking

                           8.4.2.4 Strategic initiatives

                      8.4.3 Accuray Incorporated

                           8.4.3.1 Company overview

                           8.4.3.2 Financial performance

                           8.4.3.3 Product benchmarking

                           8.4.3.4 Strategic initiatives

                      8.4.4 Ion Beam Applications (IBA)

                           8.4.4.1 Company overview

                           8.4.4.2 Financial performance

                           8.4.4.3 Product benchmarking

                           8.4.4.4 Strategic initiatives

                      8.4.5 C.R. BARD, INC. (BD)

                           8.4.5.1 Company overview

                           8.4.5.2 Financial performance

                           8.4.5.3 Product benchmarking

                           8.4.5.4 Strategic initiatives

                      8.4.6 Isoray Medical

                           8.4.6.1 Company overview

                           8.4.6.2 Financial performance

                           8.4.6.3 Product benchmarking

                           8.4.6.4 Strategic initiatives

                      8.4.7 Mevion Medical Systems, Inc.

                           8.4.7.1 Company overview

                           8.4.7.2 Product benchmarking

                           8.4.7.3 Strategic initiatives

                      8.4.8 Nordion Inc.

                           8.4.8.1 Company overview

                           8.4.8.2 Product benchmarking

                           8.4.8.3 Strategic initiatives

                      8.4.9 NTP Radioisotopes SOC Ltd.

                           8.4.9.1 Company overview

                           8.4.9.2 Financial performance

                           8.4.9.3 Product benchmarking

                           8.4.9.4 Strategic initiatives

                      8.4.10 Curium Pharma

                           8.4.10.1 Company overview

                           8.4.10.2 Product benchmarking

                      8.4.11 Viewray Technologies, Inc.

                           8.4.11.1 Company Overview

                           8.4.11.2 Product Benchmarking

                           8.4.11.3 Strategic Initiatives

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert